Leo Pharma introduces whistleblower system
The Danish drug manufacturer Leo Pharma will be launching a new whistleblower system, at the same time the company extends its anti-corruption policy, due in part to strict regulations from the UK.
by Henrik Tüchsen
One of Denmark’s largest medical outfits, Leo Pharma, is currently implementing a new whistleblower system in the company.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
